Dr Reddy’s Lab to Approach Regulator for Single-Dose Sputnik Light Jab

Share Us

280
Dr Reddy’s Lab to Approach Regulator for Single-Dose Sputnik Light Jab
20 May 2022
4 min read

Podcast

News Synopsis

A senior official from the city-based pharmaceutical company hopes that Reddy's Laboratories will be able to go to regulators for a single dose of the Sputnik Light vaccine as a booster by late June or early July. 

CEO Deepak Sapra at Dr. Reddy's told reporters that the company is currently suspending Sputnik M, a COVID-19 vaccine for children, and revising the price of Sputnik Light.

Currently, Sputnik Light is undergoing clinical trials as a universal booster. This means that anyone who has ever taken the vaccine, whether Covishield or Covaxin, can take Sputnik Light as a universal booster if we get a favorable result in our clinical trials.

In February, the Drugs Controller General of India (DCGI) approved a one-shot Sputnik Light vaccine for limited emergency use in India.

Dr. Reddy's partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and commercialize the vaccine in India. In April 2021, DCGI approved a double-dose Sputnik V vaccine for limited use in an emergency situation in India.

TWN In-Focus